1Briani C, Zara G, Rondinone R, et al. Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus[J]. Autoimrnunity, 2005,38 (7) : 549-555.
2Sayarlioglu M, Kotan MC, Topcu N, et al. Treatment of recurrent perforating intestinal ulcers with thalidomide in Behcet's disease[J]. Ann Pharmacother,2004,38(5) :808-811.
3Gockel HR, Lugering A, Heidemann J, et al. Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway[J]. Immunol,2004,172(8):5103-5109.
4Pratt G, Goodyear O, Moss P, et al. Immunodeficiency and immunotherapy in multiple myeloma[J].Br J Haematol, 2007,138(5) : 563-579.
5Haslett PA,Corral LG,Albert M, et al. Thalidomide costimulates primary human T lymphocytes preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8 subset[J].J Exp Med, 1998,187(5):1885-1892.
6LeBlanc R, Hidesshima T,Catley LP, et al. Immunomodutory drug costimulates T cells via the B7-CD28 pathay[J]. Blood, 2004,103 (5) : 1787-1790.
